Palmitic Acid methyl ester (CAS 112-39-0)

Palmitic Acid methyl ester is a 17 carbon saturated fatty acid ester. This agent has also been reported to cause autolysis of membranous structures, especially mitochondria. Studies on rat superior cervical ganglion (SCG) suggest that Palmitic Acid methyl ester is released from SCG and induces significant aortic dilation. Furthermore, this compound displays the ability to inhibit phagocytic activity and NO production of certain cells. Additionally, Palmitic Acid methyl ester appears to reduce levels of TNFalpha, PGE2, and IL-10 without affecting ATP levels. Palmitic Acid methyl ester is an inhibitor of NF kappa B. It presents as a white, waxy solid with solubility in organic solvents and a faint, recognizable scent. This compound occurs naturally in certain plant and animal fats and oils, and it is employed as a food additive and preservative. In scientific and medical research, Palmitic Acid methyl ester plays a significant role. It aids in the examination of fatty acid structure and properties, as well as the assessment of how fatty acid esters impact enzymes and other proteins. The compound also contributes to the exploration of lipid metabolism and its association with diseases.